Skip to content
Screener

Bausch Health Companies BHC Debt-to-equity

Discontinued — last reported Q4 '20

Debt-to-equity at other companies

Bausch + Lomb logo
Bausch + LombBLCO
0.8×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.6×-0.1×
Staar Surgical logo
Staar SurgicalSTAA
0.1×0.0×
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
3.1×-0.6×
Ardelyx logo
ArdelyxARDX
1.7×+0.2×
AbbVie logo
AbbVieABBV
46.6×+38.6×

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Current ratio1.3×0.0×

Where this comes from

Calculated from Bausch Health Companies’s reported figures.

total debt/total stockholders equity=45.2×

Based on the most recent quarter.

The source filing: Bausch Health Companies’s 10-K, filed February 23, 2023. Open the filing →

Filed
Feb 23, 2023
Fiscal year
FY2022
Accession
0000885590-23-000009

FAQ

What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.